Evidence map›Paper›PMID 38475347›Full record

ReviewPolymers2024

Trends in the Incorporation of Antiseptics into Natural Polymer-Based Nanofibrous Mats.

Lenka Piskláková, Kristýna Skuhrovcová, Tereza Bártová, Julie Seidelmannová, Štěpán Vondrovic, Vladimír Velebný

Abstract readReview
In one paragraph

Review in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lenka PisklákováContipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.ORCID 0000-0002-0699-7599
Kristýna SkuhrovcováContipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
Tereza BártováContipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
Julie SeidelmannováContipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
Štěpán VondrovicContipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
Vladimír VelebnýContipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanofibrous materials represent a very promising form of advanced carrier systems that can be used industrially, especially in regenerative medicine as highly functional bandages, or advanced wound dressings. By incorporation of antimicrobial additives directly into the structure of the nanofiber carrier, the functionality of the layer is upgraded, depending on the final requirement-bactericidal, bacteriostatic, antiseptic, or a generally antimicrobial effect. Such highly functional nanofibrous layers can be prepared mostly by electrospinning technology from both synthetic and natural polymers. The presence of a natural polymer in the composition is very advantageous. Especially in medical applications where, due to the presence of the material close to the human body, the healing process is more efficient and without the occurrence of an unwanted inflammatory response. However, converting natural polymers into nanofibrous form, with a homogeneously distributed and stable additive, is a great challenge. Thus, a combination of natural and synthetic materials is often used. This review clearly summarizes the issue of the incorporation and effectiveness of different types of antimicrobial substances, such as nanoparticles, antibiotics, common antiseptics, or substances of natural origin, into electrospun nanofibrous layers made of mostly natural polymer materials. A section describing the problematic aspects of antimicrobial polymers is also included.

Indexed as

antisepticsbandagechitosanelectrospinninghyaluronic acidnanofibersnanoparticleswound healing

Identifiers

PMID38475347
PMCPMC10935236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.